Medicines Patent Pool

Nov 11, 2020

Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies

Jul 30, 2019

Five Years on, 3.9 Million People in the Developing World Have Access to HIV Treatment Dolutegravir, Thanks to Access-oriented Voluntary Licensing Agreements

Nov 12, 2018

The Medicines Patent Pool Signs Licence with AbbVie to Expand Access to Key Hepatitis C Treatment, Glecaprevir/Pibrentasvir

May 24, 2018

The Medicines Patent Pool Presents New Five-Year Strategy for Improving Access to Priority Treatments in Developing Countries

May 02, 2018

The Medicines Patent Pool Adds New Suppliers from South Africa and South Korea to its Growing Generic Manufacturing Network

Apr 19, 2018

The Medicines Patent Pool Governance Board Appoints Charles Gore as New MPP Executive Director

Oct 04, 2017

The Medicines Patent Pool and Gilead Sciences Sign Licence for Bictegravir

Jul 25, 2017

Bristol-Myers Squibb, Medicines Patent Pool Extend Licence for Atazanavir to 122 Developing Countries

Jul 03, 2017

The Medicines Patent Pool Governance Board Appoints Marie-Paule Kieny as New Chair